Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Verenium Corporation Stories

2013-05-28 08:28:37

-- Deltazym® APS protease improves process economics in corn ethanol production-- SAN DIEGO, May 28, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that the Company will introduce Deltazym(®) APS protease for use in corn ethanol operations, at the upcoming 2013 International Fuel Ethanol Workshop (FEW) to be held June 10 - 13, 2013...

2013-05-23 08:27:40

SAN DIEGO, May 23, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that Jeffrey Black, Chief Financial Officer, will present at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO) Mr. Black will present at the Second Annual Marcum LLP Microcap Conference on Thursday, May 30, 2013 at the Grand Hyatt Hotel in...

2013-05-02 08:37:50

SAN DIEGO, May 2, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will release first quarter 2013 financial results on Thursday, May 9, 2013 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Thursday, May 9, 2013 at 5:00 p.m. ET. (Logo:...

2013-03-27 16:27:27

-- Company outperforms 2012 revenue, gross profit and operating loss guidance -- SAN DIEGO, Calif., March 27, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the fourth quarter and year ended December 31, 2012. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO) Company Highlights...

2013-03-18 08:29:05

SAN DIEGO, March 18, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will release fourth quarter and year end 2012 financial results on Wednesday, March 27, 2013 after market close. In conjunction with the release, the Company will host a conference call with live webcast on Wednesday, March 27, 2013 at 5:00 p.m. ET. (Logo:...

2013-03-14 16:28:02

-- Revenue and product gross profit expected to exceed 2012 guidance -- SAN DIEGO, March 14, 2013 /PRNewswire/ -- Verenium Corporation (the "Company") (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced certain preliminary financial results for its year ended December 31, 2012. The Company intends to provide fourth quarter and full year audited 2012 financial results on Wednesday,...

2013-03-12 08:28:51

SAN DIEGO, March 12, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that James Levine, President and Chief Executive Officer, will present at the upcoming 25(th) Annual ROTH Conference. The presentation is scheduled to begin at 5:30 p.m. PT on Tuesday, March 19, 2013 at the Ritz-Carlton, Laguna Niguel in Dana Point, CA. (Logo:...

2013-03-09 23:03:16

New Market Research Report Added In MarketResearchReports.Biz Reports: Database Global Industrial Enzymes Market 2012-2016. To Buy The copy Of This Report: http://www.marketresearchreports.biz/analysis-details/global-industrial-enzymes-market-2012-2016 (PRWEB) March 09, 2013 TechNavio's analysts forecast the Global Industrial Enzymes market to grow at a CAGR of 7.49 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the end-user...

2013-02-26 08:28:57

-- Adds strong global commercial operations experience -- SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that Michael Zak will be leaving its Board of Directors effective March 31, 2013, and that Holger Liepmann will be appointed to its Board of Directors, also effective March 31, 2013. (Logo:...

2013-02-04 08:22:09

SAN DIEGO, Feb. 4, 2013 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that the Company is a sponsor of the Renewable Fuels Association's (RFA) 18(th) Annual National Ethanol Conference. The conference is taking place February 5 - 7, 2013 at the Wynn Las Vegas in Las Vegas, Nevada. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO) The...